Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen Safety in NAFLD
NCT02194894Withdrawn
- Sponsor
- University of Southern California
- Start
- Jun 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acetaminophen in pain and fever (2 arms), sponsored by University of Southern California. Primary endpoint: Whether or not NAFLD patients are more prone to APAP toxicity at 14 days. Planned start Jun 2014; status: withdrawn.
02
Drugs
acetaminophen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT02194894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194894.